California State Teachers Retirement System Increases Stake in Kymera Therapeutics, Inc. $KYMRMarket Beat·Aug 8 at 02:44 AMKYMR-0.02%
Kymera Therapeutics (KYMR) Stock Faces A Revenue Durability ReckoningSimplywall·Aug 6 at 04:56 AMKYMR-0.02%
Key facts: Kymera (KYMR) Q2 $65M; $1.5B cash; KT-621 data end-2026TradingView·Aug 6 at 02:15 AMKYMR-0.02%SNY+1.26%
Kymera Therapeutics (NASDAQ:KYMR) Releases Earnings Results, Beats Estimates By $0.09 EPSMarket Beat·Aug 5 at 01:41 PMKYMR-0.02%
KYMR: KT-621 and KT-579 advance rapidly, with $1.5B cash runway supporting late-stage pipelineQuartr·Aug 5 at 10:15 AMKYMR-0.02%
KYMR: Q2 2026 revenue surged, net loss narrowed, and clinical pipeline advanced toward key milestonesQuartr·Aug 5 at 08:44 AMKYMR-0.02%
Kymera Therapeutics posts corporate deck outlining push to develop oral targeted protein degraders for immunologyPUBT·Aug 5 at 07:09 AMKYMR-0.02%
Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business UpdateUnusual Whales·Aug 5 at 06:55 AMKYMR-0.02%
Kymera Q2 2026 Earnings: Milestone Revenue Narrows Net LossTradingKey·Aug 5 at 06:45 AMKYMR-0.02%GILD+3.25%
Kymera Therapeutics | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 65 MEarnings Watch·Aug 5 at 06:12 AMKYMR-0.02%
Kymera Therapeutics (KYMR) Could Be 23% Undervalued On Its New CMO AppointmentSimplywall·Aug 1 at 06:17 PMKYMR-0.02%
This SK Hynix Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursdaybenzinga_article·Jul 30 at 10:41 AMACTU+6.06%SKHY-9.20%
Kymera Therapeutics files initial beneficial ownership statement for Chief Medical Officer Terence RooneyPUBT·Jul 27 at 05:26 PMKYMR-0.02%
Kymera Therapeutics names Terence Rooney chief medical officer as Jared Gollob retiresPUBT·Jul 27 at 03:01 PMKYMR-0.02%
